Patents by Inventor Bert DEVRIENDT

Bert DEVRIENDT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20240392036
    Abstract: The present invention relates to antibodies and antigen-binding fragments that bind specifically to amino peptidase N, fusion constructs and uses thereof, in particular for the targeted delivery of molecules. More specific, the invention provides methods for vaccination, in particular oral vaccination inducing both mucosal and systemic immune responses and methods for treating, reducing or preventing gastrointestinal diseases using said antibodies or fragments.
    Type: Application
    Filed: September 13, 2022
    Publication date: November 28, 2024
    Applicant: Universiteit Gent
    Inventors: Bert Devriendt, Eric Cox
  • IMMUNOGLOBULIN SINGLE DOMAIN ANTIBODIES FOR DELIVERY OF MUCOSAL VACCINES
    Publication number: 20230076670
    Abstract: The present invention relates to single-domain antibodies that specifically bind aminopeptidase N (APN), and more in particular to polypeptides, and nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the single-domain antibodies of the present invention are capable of targeting a moiety to a mucosal surface.
    Type: Application
    Filed: January 15, 2021
    Publication date: March 9, 2023
    Inventors: Eric COX, Bert DEVRIENDT, Anna DEPICKER